Mingde Xia is the founder of Innolake Biopharm. Innolake Biopharm has raised $76M in total funding. Latest round: Pre-A. Based in China.
Mingde Xia is the Founder, Chairman, and CEO of Innolake Biopharm, a clinical-stage biotech company founded in December 2020. The company focuses on developing innovative medicines for cancer and autoimmune diseases, with pipeline candidates including ILB-2109 and ILB-2102.
Full founder directory · Investor directory · Company funding database · Fundraising library